#DDDD I have been holding back this post &amp; think it is very exciting reply from 4D on FDA fast tracking approval of MRx0518 combo treat with Keytruda &amp; skipping Phase III trials. Main stream application near future? Transform 4D &amp; MSD revenue #MRK $MRK
https://t.co/H114Y1KGdD https://t.co/PIYX9KY0Yy